Toll-like receptor 4 regulates lipopolysaccharide-induced inflammation and lactation insufficiency in a mouse model of mastitis

Biology of Reproduction

Volumn 90, Issue 5, 2014, Pages

  Glynn, Danielle J ^a   Hutchinson, Mark R ^b   Ingman, Wendy V ^a,b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Inflammation; Lactation; Mammary gland; Mastitis; Toll like receptor

Indexed keywords

CXCL1 CHEMOKINE; CYTOKINE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MATRIGEL; MILK PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; STAT5 PROTEIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENOTYPE; INFLAMMATION; LACTATION DISORDER; MACROPHAGE; MASTITIS; MILK PRODUCTION; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SERUM; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CHI SQUARE DISTRIBUTION; DISEASE MODEL; GENETICS; GERMFREE ANIMAL; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; INNATE IMMUNITY; KNOCKOUT MOUSE; LACTATION; NEWBORN; SIGNAL TRANSDUCTION;

ANIMALS; ANIMALS, NEWBORN; CHI-SQUARE DISTRIBUTION; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; GENOTYPE; IMMUNITY, INNATE; IMMUNOHISTOCHEMISTRY; LACTATION; LIPOPOLYSACCHARIDES; MASTITIS; MICE, INBRED BALB C; MICE, KNOCKOUT; SIGNAL TRANSDUCTION; SPECIFIC PATHOGEN-FREE ORGANISMS; TOLL-LIKE RECEPTOR 4;

EID: 84903766074     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.114.117663     Document Type: Article

References (61)

1. Tang L, Lee AH, Qiu L, Binns CW. Mastitis in Chinese breastfeeding mothers: a prospective cohort study. Breastfeed Med 2014; 9:35-38.
2. Scott JA, Robertson M, Fitzpatrick J, Knight C, Mulholland S. Occurrence of lactational mastitis and medical management: a prospective cohort study in Glasgow. Int Breastfeed J 2008; 3:21.
3. Kinlay JR, O'Connell DL, Kinlay S. Risk factors for mastitis in breastfeeding women: results of a prospective cohort study. Aust N Z J Public Health 2001; 25:115-120.
4. Foxman B, D'Arcy H, Gillespie B, Bobo JK, Schwartz K. Lactation mastitis: occurrence and medical management among 946 breastfeeding women in the United States. Am J Epidemiol 2002; 155:103-114.
5. Vogel A, Hutchison BL, Mitchell EA. Mastitis in the first year postpartum. Birth 1999; 26:218-225.
6. Lunney KM, IliffP, Mutasa K, Ntozini R, Magder LS, Moulton LH, Humphrey JH. Associations between breast milk viral load, mastitis, exclusive breast-feeding, and postnatal transmission of HIV. Clin Infect Dis 2010; 50:762-769.
7. Semba RD. Mastitis and transmission of human immunodeficiency virus through breast milk. Ann N Y Acad Sci 2000; 918:156-162.
8. Wambach KA. Lactation mastitis: a descriptive study of the experience. J Hum Lact 2003; 19:24-34.
9. Amir LH, Forster D, McLachlan H, Lumley J. Incidence of breast abscess in lactating women: report from an Australian cohort. BJOG 2004; 111: 1378-1381.
10. Fetherston C. Characteristics of lactation mastitis in a Western Australian cohort. Breastfeed Rev 1997; 5:5-11.
11. Michie C, Lockie F, Lynn W. The challenge of mastitis. Arch Dis Child 2003; 88:818-821.
12. Wockel A, Beggel A, Rucke M, Abou-Dakn M, Arck P. Predictors of inflammatory breast diseases during lactation-results of a cohort study. Am J Reprod Immunol 2010; 63:28-37.
13. Barkema HW, Green MJ, Bradley AJ, Zadoks RN. Invited review: the role of contagious disease in udder health. J Dairy Sci 2009; 92:4717-4729.
14. Osterman KL, Rahm VA. Lactation mastitis: bacterial cultivation of breast milk, symptoms, treatment, and outcome. J Hum Lact 2000; 16:297-302.
15. Kvist LJ, Larsson BW, Hall-Lord ML, Steen A, Schalen C. The role of bacteria in lactational mastitis and some considerations of the use of antibiotic treatment. Int Breastfeed J 2008; 3:6.
16. Jost T, Lacroix C, Braegger C, Chassard C. Assessment of bacterial diversity in breast milk using culture-dependent and culture-independent approaches. Br J Nutr 2013; 110:1253-1262.
17. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997; 10:505-520.
18. Zdrazilek J, Petras P, Sramova H, Subertova V, Maskova L. Staphylococcus aureus at a maternity ward. I. Colonization of mothers and neonates and survival of various S. aureus types in colonized individuals. J Hyg Epidemiol Microbiol Immunol 1988; 32:49-57.
19. Barbosa-Cesnik C, Schwartz K, Foxman B. Lactation mastitis. JAMA 2003; 289:1609-1612.
20. Crepinsek MA, Crowe L, Michener K, Smart NA. Interventions for preventing mastitis after childbirth. Cochrane Database Syst Rev 2012; 10: CD007239.
21. Jahanfar S, Ng CJ, Teng CL. Antibiotics for mastitis in breastfeeding women. Cochrane Database Syst Rev 2013; 2:CD005458.
22. Fetherston CM, Lai CT, Hartmann PE. Relationships between symptoms and changes in breast physiology during lactation mastitis. Breastfeed Med 2006; 1:136-145.
23. Fetherston CM, Wells JI, Hartmann PE. Severity of mastitis symptoms as a predictor of C-reactive protein in milk and blood during lactation. Breastfeed Med 2006; 1:127-135.
24. Thomsen AC, Espersen T, Maigaard S. Course and treatment of milk stasis, noninfectious inflammation of the breast, and infectious mastitis in nursing women. Am J Obstet Gynecol 1984; 149:492-495.
25. Thomsen AC, Hansen KB, Moller BR. Leukocyte counts and microbiologic cultivation in the diagnosis of puerperal mastitis. Am J Obstet Gynecol 1983; 146:938-941.
26. Zheng J, Watson AD, Kerr DE. Genome-wide expression analysis of lipopolysaccharide-induced mastitis in a mouse model. Infect Immun 2006; 74:1907-1915.
27. Mizuno K, Hatsuno M, Aikawa K, Takeichi H, Himi T, Kaneko A, Kodaira K, Takahashi H, Itabashi K. Mastitis is associated with IL-6 levels and milk fat globule size in breast milk. J Hum Lact 2012; 28:529-534.
28. Mogensen TH. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev 2009; 22:240-273.
29. Kumar H, Kawai T, Akira S. Pathogen recognition by the innate immune system. Int Rev Immunol 2011; 30:16-34.
30. Kawai T, Akira S. Pathogen recognition with Toll-like receptors. Curr Opin Immunol 2005; 17:338-344.
31. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, Akira S. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 1999; 162:3749-3752.
32. Stein T, Morris JS, Davies CR, Weber-Hall SJ, Duffy MA, Heath VJ, Bell AK, Ferrier RK, Sandilands GP, Gusterson BA. Involution of the mouse mammary gland is associated with an immune cascade and an acute-phase response, involving LBP, CD14 and STAT3. Breast Cancer Res 2004; 6: R75-91.
33. O'Brien J, Martinson H, Durand-Rougely C, Schedin P. Macrophages are crucial for epithelial cell death and adipocyte repopulation during mammary gland involution. Development 2012; 139:269-275.
34. Miao JF, Zhu YM, Gu BB, Wang XB, Zou SX, Deng YE. Evaluation of the changes of immune cells during lipopolysaccharide-induced mastitis in rats. Cytokine 2007; 40:135-143.
35. Gu B, Zhu Y, Zhu W, Miao J, Deng Y, Zou S. Retinoid protects rats against neutrophil-induced oxidative stress in acute experimental mastitis. Int Immunopharmacol 2009; 9:223-229.
36. Elazar S, Gonen E, Livneh-Kol A, Rosenshine I, Shpigel NY. Neutrophil recruitment in endotoxin-induced murine mastitis is strictly dependent on mammary alveolar macrophages. Vet Res 2010; 41:10.
37. Gonen E, Vallon-Eberhard A, Elazar S, Harmelin A, Brenner O, Rosenshine I, Jung S, Shpigel NY. Toll-like receptor 4 is needed to restrict the invasion of Escherichia coli P4 into mammary gland epithelial cells in a murine model of acute mastitis. Cell Microbiol 2007; 9: 2826-2838.
38. Nish S, Medzhitov R. Host defense pathways: role of redundancy and compensation in infectious disease phenotypes. Immunity 2011; 34: 629-636.
39. Kayagaki N, Wong MT, Stowe IB, Ramani SR, Gonzalez LC, Akashi-Takamura S, Miyake K, Zhang J, Lee WP, Muszynski A, Forsberg LS, Carlson RW, et al. Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science 2013; 341:1246-1249.
40. Na HY, Mazumdar K, Moon HJ, Chang S, Seong SY. TLR4-independent and PKR-dependent interleukin 1 receptor antagonist expression upon LPS stimulation. Cell Immunol 2009; 259:33-40.
41. Yao L, Yago T, Shao B, Liu Z, Silasi-Mansat R, Setiadi H, Lupu F, McEver RP. Elevated CXCL1 expression in gp130-deficient endothelial cells impairs neutrophil migration in mice. Blood 2013; 122:3832-3842.
42. Martire-Greco D, Rodriguez-Rodrigues N, Landoni VI, Rearte B, Isturiz MA, Fernandez GC. Interleukin-10 controls human peripheral PMN activation triggered by lipopolysaccharide. Cytokine 2013; 62:426-432.
43. Thompson-Crispi KA, Miglior F, Mallard BA. Incidence rates of clinical mastitis among Canadian Holsteins classified as high, average, or low immune responders. Clin Vaccine Immunol 2013; 20:106-112.
44. Sharma BS, Leyva I, Schenkel F, Karrow NA. Association of toll-like receptor 4 polymorphisms with somatic cell score and lactation persistency in Holstein bulls. J Dairy Sci 2006; 89:3626-3635.
45. Wang X, Xu S, Gao X, Ren H, Chen J. Genetic polymorphism of TLR4 gene and correlation with mastitis in cattle. J Genet Genomics 2007; 34: 406-412.
46. Catalani E, Amadori M, Vitali A, Lacetera N. Short communication: lymphoproliferative response to lipopolysaccharide and incidence of infections in periparturient dairy cows. J Dairy Sci 2013; 96:7077-7081.
47. Fetherston C. Risk factors for lactation mastitis. J Hum Lact 1998; 14: 101-109.
48. El Mezayen R, El Gazzar M, Seeds MC, McCall CE, Dreskin SC, Nicolls MR. Endogenous signals released from necrotic cells augment inflammatory responses to bacterial endotoxin. Immunol Lett 2007; 111:36-44.
49. Samuvel DJ, Sundararaj KP, Nareika A, Lopes-Virella MF, Huang Y. Lactate boosts TLR4 signaling and NF-kappaB pathway-mediated gene transcription in macrophages via monocarboxylate transporters and MD-2 up-regulation. J Immunol 2009; 182:2476-2484.
50. Davis SR, Farr VC, Prosser CG, Nicholas GD, Turner SA, Lee J, Hart AL. Milk L-lactate concentration is increased during mastitis. J Dairy Res 2004; 71:175-181.
51. Frank MG, Watkins LR, Maier SF. Stress-induced glucocorticoids as a neuroendocrine alarm signal of danger. Brain Behav Immun 2013; 33:1-6.
52. Garate I, Garcia-Bueno B, Madrigal JL, Bravo L, Berrocoso E, Caso JR, Mico JA, Leza JC. Origin and consequences of brain Toll-like receptor 4 pathway stimulation in an experimental model of depression. J Neuroinflammation 2011; 8:151.
53. Rosen JM, Wyszomierski SL, Hadsell D. Regulation of milk protein gene expression. Annu Rev Nutr 1999; 19:407-436.
54. Kesaraju P, Jaini R, Johnson JM, Altuntas CZ, Gruden JJ, Sakalar C, Tuohy VK. Experimental autoimmune breast failure: a model for lactation insufficiency, postnatal nutritional deprivation, and prophylactic breast cancer vaccination. Am J Pathol 2012; 181:775-784.
55. Filteau SM, Lietz G, Mulokozi G, Bilotta S, Henry CJ, Tomkins AM. Milk cytokines and subclinical breast inflammation in Tanzanian women: effects of dietary red palm oil or sunflower oil supplementation. Immunology 1999; 97:595-600.
56. Morton JA. The clinical usefulness of breast milk sodium in the assessment of lactogenesis. Pediatrics 1994; 93:802-806.
57. Lambe M, Johansson AL, Altman D, Eloranta S. Mastitis and the risk of breast cancer. Epidemiology 2009; 20:747-751.
58. Resler AJ, Malone KE, Johnson LG, Malkki M, Petersdorf EW, McKnight B, Madeleine MM. Genetic variation in TLR or NFkappaB pathways and the risk of breast cancer: a case-control study. BMC Cancer 2013; 13:219.
59. Brasky TM, Bonner MR, Moysich KB, Ambrosone CB, Nie J, Tao MH, Edge SB, Kallakury BV, Marian C, Trevisan M, Shields PG, Freudenheim JL. Non-steroidal anti-inflammatory drug (NSAID) use and breast cancer risk in the Western New York Exposures and Breast Cancer (WEB) Study. Cancer Causes Control 2010; 21:1503-1512.
60. Ready A, Velicer CM, McTiernan A, White E. NSAID use and breast cancer risk in the VITAL cohort. Breast Cancer Res Treat 2008; 109: 533-543.
61. O'Brien J, Hansen K, Barkan D, Green J, Schedin P, O'Brien J, Hansen K, Barkan D, Green J, Schedin P. Non-steroidal anti-inflammatory drugs target the pro-tumorigenic extracellular matrix of the postpartum mammary gland. Int J Dev Biol 2011; 55:745-755.